Geoffrey A. McKay

Geoffrey A. McKay

Auto-generated profile, based on publicly available information

Geoffrey A. McKay

Meakins-Christie Laboratories, Research Institute of the McGill University Health Centre

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2023 in Nature Nanotechnology
Verified
Journal Article
Closed access
PDF file
TATamer AbdElFatah
Tamer AbdElFatah
MJMahsa Jalali
Mahsa Jalali
SYSripadh Guptha Yedire
Sripadh Guptha Yedire
IHImman I. Hosseini
Imman I. Hosseini
CMCarolina del Real Mata
Carolina del Real Mata
SMSara Mahshid
Sara Mahshid

23 June 2020 in Nano Letters
Verified
Journal Article
Open access
AVAmin Valiei
Amin Valiei
NLNicholas Lin
Nicholas Lin
JBJean-François Bryche
Jean-François Bryche
GMGeoffrey McKay
Geoffrey McKay
MCMichael Canva
Michael Canva
NTNathalie Tufenkji
Nathalie Tufenkji
Nanopillars have been shown to mechanically damage bacteria, suggesting a promising strategy for future antibacterial surfaces. However, the mechanisms underlying this phenomena remain unclear, which ultimately limits translational potential toward real-world applications. Using real-time and end-point analysis techniques, we demonstrate that in contrast to initial expectations, bacteria on multiple hydrophilic “mechano-bactericidal” surfaces remained viable unless exposed to a moving air–liquid interface, which caused considerable cell death. Reasoning that normal forces arising from surface tension may underlie this mechano-bactericidal activity, we developed computational and experimental models to estimate, manipulate, and recreate the impact of these forces. Our experiments together demonstrate that a critical level of external force acting on cells attached to nanopillar surfaces can rapidly deform and rupture bacteria. These studies provide fundamental physical insight into how nanopillar surfaces can serve as effective antibacterial materials and suggest use-conditions under which such nanotechnology approaches may provide practical value.

10 March 2021 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
LHLisa C. Hennemann
Lisa C. Hennemann
SLShantelle L. LaFayette
Shantelle L. LaFayette
JMJulien K. Malet
Julien K. Malet
PBPerrine Bortolotti
Perrine Bortolotti
TYTianxiao Yang
Tianxiao Yang
DNDao Nguyen
Dao Nguyen
Pseudomonas aeruginosacauses chronic airway infections, a major determinant of lung inflammation and damage in cystic fibrosis (CF). Loss-of-functionlasRmutants commonly arise during chronic CF infections, are associated with accelerated lung function decline in CF patients and induce exaggerated neutrophilic inflammation in model systems. In this study, we investigated howlasRmutants modulate airway epithelial membrane bound ICAM-1 (mICAM-1), a surface adhesion molecule, and determined its impact on neutrophilic inflammationin vitroandin vivo. We demonstrated that LasR-deficient strains induce increased mICAM-1 levels in airway epithelial cells compared to wild-type strains, an effect attributable to the loss of mICAM-1 degradation by LasR-regulated proteases and associated with enhanced neutrophil adhesion. In a subacute airway infection model, we also observed thatlasRmutant-infected mice displayed greater airway epithelial ICAM-1 expression and increased neutrophilic pulmonary inflammation. Our findings provide new insights into the intricate interplay betweenlasRmutants, LasR-regulated proteases and airway epithelial ICAM-1 expression, and reveal a new mechanism involved in the exaggerated inflammatory response induced bylasRmutants.

27 January 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
DKDusik Kim
Dusik Kim
JLJie Liao
Jie Liao
NSNathan B. Scales
Nathan B. Scales
CMCarolina Martini
Carolina Martini
XLXiaojie Luan
Xiaojie Luan
JHJohn William Hanrahan
John William Hanrahan
The airway mucosal microenvironment is crucial for host defense against inhaled pathogens but remains poorly understood. We report here that the airway surface normally undergoes surprisingly large excursions in pH during breathing that can reach pH 9.0 during inhalation, making it the most alkaline fluid in the body. Transient alkalinization requires luminal bicarbonate and membrane-bound carbonic anhydrase 12 (CA12) and is antimicrobial. Luminal bicarbonate concentration and CA12 expression are both reduced in cystic fibrosis (CF), and mucus accumulation both buffers the pH and obstructs airflow, further suppressing the oscillations and bacterial-killing efficacy. Defective pH oscillations may compromise airway host defense in other respiratory diseases and explain CF-like airway infections in people with CA12 mutations.

1 January 1996 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
JCJames R. Cox
James R. Cox
GMGeoffrey A. McKay
Geoffrey A. McKay
GWGerard D. Wright
Gerard D. Wright
ESEngin Serpersu
Engin Serpersu

1 October 2009 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
FAFrancis F. Arhin
Francis F. Arhin
GMGeoffrey A. McKay
Geoffrey A. McKay
SBSylvain Beaulieu
Sylvain Beaulieu
ISIngrid Sarmiento
Ingrid Sarmiento
TPThomas. R. Parr
Thomas. R. Parr
GMGregory Moeck
Gregory Moeck